Dr. Shirin Mazumder, MD

Dr. Mazumder practices at Methodist University Hospital in Memphis, Tennessee, part of Methodist Le Bonheur Healthcare.

Dr. Mazumder's NPI, 1396921623, was assigned on January 16, 2008. Dr. Mazumder graduated from Rush Medical College in 2005. Dr. Mazumder's Tennessee license number on file is 47374.

Dr. Mazumder's primary practice is Methodist University Hospital, at 1265 Union Ave Suite 700, Memphis, TN 38104 in Shelby County. The practice phone is (901) 516-8274.

Dr. Mazumder's primary practice is Methodist University Hospital in Memphis, Tennessee, part of Methodist Le Bonheur Healthcare. The medical group on file is UT Neurology. Dmand AI also links Dr. Mazumder to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mazumder practices, 3 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Mazumder's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Mazumder is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Mazumder's licenses on file in 3 states: Tennessee, Missouri and Illinois.

Dmand AI lists acute skin infection, hiv/aids, joint or bone infection and pneumonia among the conditions Dr. Mazumder treats.

CMS data shows 168 Medicare services from Dr. Mazumder across 3 procedure codes in 2024, for 105 Medicare patients. Medicare paid $6,824 for them.

CMS counts 105 Medicare patients who saw Dr. Mazumder in 2024. The largest group is 65 to 74, with 47 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mazumder's median patient age at 61, with 34% women.

In 2024, Dr. Mazumder wrote 1,865 Medicare Part D claims for 189 patients. 28% of them were for generic drugs. CMS names the drug for 1,719 of them, across 28 drugs with 11 or more claims each, at $4,501,222 in total drug cost. In 2023, CMS named 1,674 claims across 30 drugs.

Dr. Mazumder accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mazumder as offering telehealth.

Dmand AI links 19 papers to Dr. Mazumder, published from 2009 to 2022. 2014 was the busiest year, with 3. The most frequent topics are Anti-Bacterial Agents, Antifungal Agents and Bacteremia. Dr. Mazumder has published most often in Am J Med Sci. Dr. Mazumder's most frequent co-authors are Kerry O. Cleveland, MD, Michael S. Gelfand, MD and Chinelo Ngozi Animalu, MD.

CMS Open Payments shows 15 general payments to Dr. Mazumder from 3 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 66% of the total. Gilead Sciences, Inc. paid the most, $1,481.

Dr. Mazumder graduated from Rush Medical College in 2005.

Dr. Mazumder is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.